Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Eigenmann

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Physiology|September 30, 2017
Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approachesMiro J Eigenmann, Tine V Karlsen, Ben-Fillippo Krippendorff, et al.
Molecular Cancer Therapeutics|December 10, 2020
Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining <i>In Vitro</i> Experiments with Systems ModelingArthur J Van De Vyver, Tina Weinzierl, Miro J Eigenmann, et al.
Journal of Pharmaceutical Sciences|December 6, 2025
An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIIIElisabeth Husar, Silke Simon, Afsaneh Abdolzade-Bavil, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Physiology|September 30, 2017
Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approachesMiro J Eigenmann, Tine V Karlsen, Ben-Fillippo Krippendorff, et al.
Molecular Cancer Therapeutics|December 10, 2020
Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining <i>In Vitro</i> Experiments with Systems ModelingArthur J Van De Vyver, Tina Weinzierl, Miro J Eigenmann, et al.
Journal of Pharmaceutical Sciences|December 6, 2025
An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIIIElisabeth Husar, Silke Simon, Afsaneh Abdolzade-Bavil, et al.
Pageof 3